Bionoid Pharma Inc.
BINP
$0.08
$0.000.00%
OTC PK
| 03/31/2012 | 03/31/2011 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -99.97% | 2,322.58% | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | -- | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -83.16% | -- | |||
| Total Current Assets | -95.10% | 1,341.13% | |||
|
|
|||||
| Total Current Assets | -95.10% | 1,341.13% | |||
| Net Property, Plant & Equipment | -38.21% | 30.85% | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | 0.00% | -9.60% | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -- | -- | |||
| Total Assets | -53.29% | 89.87% | |||
|
|
|||||
| Total Accounts Payable | 40.61% | 4.77% | |||
| Total Accrued Expenses | -59.53% | 22.50% | |||
| Short-term Debt | 49.50% | -93.49% | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 0.00% | 0.00% | |||
| Total Finance Division Other Current Liabilities | -- | -- | |||
| Total Other Current Liabilities | -- | -- | |||
| Total Current Liabilities | -40.57% | 2.09% | |||
|
|
|||||
| Total Current Liabilities | -40.57% | 2.09% | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | 49.50% | -93.49% | |||
| Capital Leases | -- | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | -40.57% | 2.09% | |||
|
|
|||||
| Common Stock & APIC | 3.01% | 98.91% | |||
| Retained Earnings | -0.28% | -80.85% | |||
| Treasury Stock & Other | 0.00% | -149.67% | |||
| Total Common Equity | 35.01% | 15.07% | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | 35.01% | 15.07% | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 35.01% | 15.07% | |||
|
|
|||||